Galibert Group Publications

Publications 2010-2015

> 2015

CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Arnaud MP, Vallée A, Robert G, Bonneau J, Leroy C, Varin-Blank N, Rio AG, Troadec MB, Galibert MD and Gandemer V.
Blood. 2015 Oct.

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.
El Hajj P, Gilot D, Migault M, Theunis A, van Kempen LC, Salés F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F.
Br J Cancer. 2015 Jun.

Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.
Pracht M*, Mogha A*, Lespagnol A, Fautrel A, Mouchet N, Le Gall F, Paumier V, Lefeuvre-Plesse C, Rioux-Leclerc N, Mosser J, Oger E, Adamski H, Galibert MD*, Lesimple T*.
J Eur Acad Dermatol Venereol. 2015 Janv / Aug. - * Equal contribution 

> 2014

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.
Pochon C, Oger E, Michel G, Dalle J, Salmon A, Nelken B, Bertrand Y, Cavé H, Cayuela J, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rohrlich P, Paillard C, Demeocq F, Schneider P, Plantaz D, Poirée M, Eliaou J, Semana G, Drunat S, Jonveaux P, Bordigoni P, Gandemer V.
Br J Haematol. 2014 Dec / April 2015.

CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells.
Delehouzé C, Godl K, Loaëc N, Bruyère C, Desban N, Oumata N, Galons H, Roumeliotis TI, Giannopoulou EG, Grenet J, Twitchell D, Lahti J, Mouchet N, Galibert MD, Garbis SD, Meijer L.
Oncogene. 2014 Dec.

Comparative transcriptional profiling of human Merkel cells and Merkel cell carcinoma.
Mouchet N, Coquart N, Lebonvallet N, Le Gall-Ianotto C, Mogha A, Fautrel A,Boulais N, Dréno B, Martin L, Hu W, Galibert MD, Misery L.
Exp Dermatol. 2014 Dec.

Skin cancer, photoprotection, and skin of color.
Dadzie OE, Jablonski NG, Mahalingam M, Dupuy A, Petit A.
J Am Acad Dermatol. 2014 Sep.

Aryl hydrocarbon receptor control of a disease tolerance defense pathway.
Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza E, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz T, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F & Puccetti P.
Nature. 2014 Jul.

AhR and Arnt differentially regulate NF-κB signaling and chemokine responses in human bronchial epithelial cells.
Øvrevik J, Låg M, Lecureur V, Gilot D, Lagadic-Gossmann D, Refsnes M, Schwarze PE, Skuland T, Becher R & Holme JA.
Cell Commun Signal. 2014 Jul.

p53 requires the stress sensor USF1 to direct appropriate cell fate decision. 
Bouafia A, Corre S, Gilot D, Mouchet N, Prince S & Galibert MD.
PLoS Genet. 2014 May.

Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.
Gandemer V, Pochon C, Oger E, Dalle JH, Michel G, Schmitt C, de Berranger E, Galambrun C, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rorhlich P, Lutz P, Demeocq F, Schneider P, Plantaz D, Poirée M, Bordigoni P.
Br J Haematol. 2014 May.

Testing chemical carcino genicity by using a transcriptomics HepaRG-based model ?
Doktorova TY, Yildirimman R, Ceelen L, Vilardell M, Vanhaecke T, Vinken M, Ates G, Heymans A, Gmuender H, Bort R, Corvi R, Phrakonkham P, Li R, Mouchet N, Chesne C, van Delft J, Kleinjans J, Castell J, Herwig R, Rogiers V.
EXCLI Journal. 2014 May.

Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.
Gillard M, Cadieu E, De Brito C, Abadie J, Vergier B, Devauchelle P, Degorce F, Dréano S, Primot A, Dorso L, Lagadic M, Galibert F, Hédan B, Galibert MD, André C.
Pigment Cell Melanoma Res. 2014 Jan.
>> Journal cover 

> 2013

Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients.
Chabbert C, Adamski H, Guillet G, Sassolas B, Misery L, Perrinaud A, Machet L, Quereux G, Esteve E, Solau-Gervais E, Saraux A, Polard E, Lesimple T, Le Gall F, Dreno B, Dupuy A.
J Eur Acad Dermatol Venereol. 2013 Dec / 2014 Nov.

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.
Caye A, Beldjord K, Mass-Malo K, Drunat S, Soulier J, Gandemer V, Baruchel A, Bertrand Y, Cavé H, Clappier E.
Haematologica. 2013 Apr.

Vemurafenib-induced eccrine squamous syringometaplasia.
Lescoat A, Droitcourt C, Stock N, Le Gall F, Dupuy A.
Dermatology. 2013 Jul.

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients.
El Hajj P, Journe F, Wiedig M, Laios I, Salès F, Galibert MD, Van Kempen LC, Spatz A, Badran B, Larsimont D, Awada A, Ghanem G.
Br J Cancer. 2013 Apr.

Aurora-a is involved in central spindle assembly through phosphorylation of ser 19 in p150glued.
Reboutier D*, Troadec MB*, Cremet JY, Chauvin L, Guen V, Salaun P, Prigent C.
J Cell Biol. 2013 Apr. - * Co-first author 

SPECT/CT for sentinel lymph node detection in patients with melan.
Dupuy A, Heusse JL.
JAMA. 2013.

> 2012

Efficacy and safety of Imatinib on Top of BFM-like Chemotherapy in Pediatric Patients with Ph+/BCR-ABL+ Acute Lymphoblastic Leukemia (Ph+ALL).
Biondi A, Schrappe M, de Lorenzo P, Castor A, Lucchini G, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Li CK, Vora A, Lönnerholm G, Aricò M, Harbott J, Saha V, Valsecchi MG - The EsPhALL study.
Lancet Oncology. 2012 Sep.

Docetaxel-induced photo-recall phenomenon.
Droitcourt C, Le Hô H, Adamski H, Le Gall F, Dupuy A.
Photodermatol Photoimmunol Photomed. 2012 Aug.

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S.
PLoS One. 2012 Jul.

Presence of putative stem cells in Merkel cell carcinomas.
Lemasson G, Coquart N, Lebonvallet N, Boulais N, Galibert MD, Marcorelles P, Misery L.
J Eur Acad Dermatol Venereol. 2012 Jun.

Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.
Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G, Schmitt C, Lejars O, Schneider P, Demeocq F, Bader-Meunier B, Bernaudin F, Perel Y, Auclerc MF, Cayuela JM, Leverger G, Baruchel A - FRALLE Group.
Haematologica. 2012 May / Nov.

Nucleophosmin/b23 activates aurora-a at the centrosome through phosphorylation of serine 89.
Reboutier D*, Troadec MB*, Crémet JY, Fukasawa K, Prigent C.
J Cell Biol, 2012 Apr. - * Co-first author 

USF-1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions. 
Baron Y*, Corre S*, Mouchet N, Vaulont S, Prince S, Galibert MD.
PLoS Genet. 2012 Jan.  - * Co-first author 

Highly Efficient siRNA and Gene Transfer into Hepatocyte-like HepaRG Cells and Primary Human Hepatocytes: New Means for Drug Metabolism and Toxicity Studies.
Laurent V, Glaise D, Nübel T, Gilot D, Corlu A and Loyer P.
In "Cytochrome P450 Protocols", Methods in Molecular Biology series, 3rd edition (ed.: Ian R. Phillips, Paul Ortiz de Montellano, Elizabeth Shephard). Humana Press, USA, 2012.

> 2011

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.
Journe F, Id Boufker H, Van Kempen L, Galibert MD, Wiedig M, Salès F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G.
Br J Cancer. 2011 Nov

Overexpression of active Aurora-C kinase results in cell transformation and tumour formation.
Khan J, Ezan F, Crémet JY, Fautrel A, Gilot D, Lambert M, Benaud C, Troadec MB, Prigent C.
PLoS One. 2011 Oct.

Targeted deletion of the mouse mitoferrin1 gene : from anemia to porphyria.
Troadec MB, Warner D, Wallace J, Thomas KR, Spangrude GJ, Phillips J, Khalimonchuk O, Paw BH, McVey Ward D, Kaplan J.
Blood. 2010 Feb / 2011 May.  
>> Journal cover 

Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes.
Martin-Chouly C, Morzadec C, Bonvalet M, Galibert MD, Fardel O, Vernhet L.
Mol Immunol. 2011 Mar.

RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity.
Gilot D, Le Meur N, Giudicelli F, Le Vée M, Lagadic-Gossmann D, Théret N, Fardel O.
PLoS One. 2011 Mar.

A 4-gene signature associated with clinical outcome in high-grade gliomas.
de Tayrac M, Aubry M, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J.
Clin Cancer Res. 2011 Jan.

Identification of distal cis-regulatory elements at the mouse mitoferrin loci using zebrafish transgenesis.
Amigo JD, Ming Yu, Troadec MB, Gwynn B, Cooney JD, Lambert AJ, Chi NC, Weiss MJ, Peters LL, Kaplan J, Cantor AB, Paw BH.
Mol Cell Biol. 2011 Jan / Apr.
>> Journal cover 

> 2010

Merkel cell polyomavirus small T antigen mRNA level is increased following in vivo UV-radiation.
Mogha A, Fautrel A, Mouchet N, Guo N, Corre S, Adamski H, Watier E, Misery L, Galibert MD.
PLoS One. 2010 Jul.

In vivo identification of solar radiation-responsive gene network: role of the p38 stress-dependent kinase. 
Mouchet N, Adamski H, Bouvet R, Corre S, Courbebaisse Y, Watier E, Mosser J, Chesné C, Galibert MD.
PLoS One. 2010 May.

CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leu kemia: Proposal for an accelerated diagnostic flowchart. 
Gandemer V, Aubry M, Roussel M, Rio AG, de Tayrac M, Vallée A, Mosser J, Ly-Sunnaram B, Galibert MD.
Leuk Res. 2010 Apr.

ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD.
Pigment Cell Melanoma Res. 2010 Feb.


Book chapters

Identification of Specific Protein/E-Box-Containing DNA Complexes: Lessons from the Ubiquitously Expressed USF Transcription Factors of the b-HLH-LZ Super Family. 
Galibert MD, Baron Y.
Methods Mol Biol. 2010.
In: "Transcription Factors: Methods and Protocols", (ed. Higgins Paul J). Springer, Humana Press, USA, 2010. - 647:391-406.

In Vivo and In Vitro Tools to Identify and Study Transcriptional Regulation of USF-1 
Galibert MD, Corre S.
Methods Mol Biol. 2010.
In: "Transcription Factors: Methods and Protocols", (ed. Higgins Paul J). Springer, Humana Press, USA, 2010. - 647:339-355. 

Subscribe to our newsletter